Patents by Inventor Christina Pham

Christina Pham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENGINEERED MEGANUCLEASES WITH RECOGNITION SEQUENCES FOUND IN THE HUMAN BETA-2 MICROGLOBULIN GENE
    Publication number: 20240052373
    Abstract: Disclosed herein are recombinant meganucleases engineered to recognize and cleave a recognition sequence present in the human beta-2 microglobulin gene. The disclosure further relates to the use of such recombinant meganucleases in methods for producing genetically-modified eukaryotic cells, and to a population of genetically-modified T cells having reduced cell-surface expression of beta-2 microglobulin.
    Type: Application
    Filed: October 20, 2023
    Publication date: February 15, 2024
    Applicant: Precision Biosciences, Inc.
    Inventors: Victor Bartsevich, Christina Pham, Aaron Martin, Derek Jantz, James Jefferson Smith, Michael G. Nicholson
  • METHODS FOR EXPANDING ANTIGEN-SPECIFIC CAR-T CELLS, COMPOSITIONS AND USES RELATED THERETO
    Publication number: 20210301255
    Abstract: Provided herein are methods for preparing and characterizing CAR-T cell cultures and preparations.
    Type: Application
    Filed: September 10, 2019
    Publication date: September 30, 2021
    Inventors: Blake T. Aftab, Christina Pham, Rhine Shen, Michelle Wu
  • ENGINEERED MEGANUCLEASES WITH RECOGNITION SEQUENCES FOUND IN THE HUMAN BETA-2 MICROGLOBULIN GENE
    Publication number: 20210032664
    Abstract: Disclosed herein are recombinant meganucleases engineered to recognize and cleave a recognition sequence present in the human beta-2 microglobulin gene. The disclosure further relates to the use of such recombinant meganucleases in methods for producing genetically-modified eukaryotic cells, and to a population of genetically-modified T cells having reduced cell-surface expression of beta-2 microglobulin.
    Type: Application
    Filed: October 19, 2020
    Publication date: February 4, 2021
    Applicant: Precision Biosciences, Inc.
    Inventors: Victor Bartsevich, Christina Pham, Aaron Martin, Derek Jantz, James Jefferson Smith, Michael G. Nicholson
  • ENGINEERED MEGANUCLEASES WITH RECOGNITION SEQUENCES FOUND IN THE HUMAN BETA-2 MICROGLOBULIN GENE
    Publication number: 20190017075
    Abstract: Disclosed herein are recombinant meganucleases engineered to recognize and cleave a recognition sequence present in the human beta-2 microglobulin gene. The disclosure further relates to the use of such recombinant meganucleases in methods for producing genetically-modified eukaryotic cells, and to a population of genetically-modified T cells having reduced cell-surface expression of beta-2 microglobulin.
    Type: Application
    Filed: December 22, 2016
    Publication date: January 17, 2019
    Applicant: Precision BioSciences, Inc.
    Inventors: Victor Bartsevich, Christina Pham, Aaron Martin, Derek Jantz, James Jefferson Smith, Michael G. Nicholson